LA JOLLA, Calif., Dec. 8, 2019 /PRNewswire/ -- Nurish.Me Inc. (Subsidiary - F/K/A Altavoz Entertainment, Inc.; OTC Pink: AVOZ) (the "Company"), an emerging leader in the dietary supplement industry for delivering clinically proven solutions for brain and immune system support, announces the release of its audited financial statements for 2017 and 2018. The Company's management is now diligently working on preparing its financial report for 2019.
Company CEO David Perez commented, "While the task of preparing and filing our financial statements has been a long and challenging process due to the reverse merger on December 18, 2018, we appreciate the thorough manner in which our independent accountants and auditing firm conducted their audit."
This press release may contain forward-looking statements that involve risks and uncertainties. These statements relate to future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology including "could," "may," "will," "should," "expect," "plan," "anticipate," "believe," "estimate," "predict," "potential," and the negative of these terms or other comparable terminology. While these forward-looking statements, and any assumptions upon which they are based, are made in good faith and reflect our current judgment regarding the direction of our business, actual results will almost always vary, sometimes materially, from any estimates, predictions, projections, assumptions, or other future performance suggested in this report. Except as required by applicable law, we do not intend to update any of the forward-looking statements so as to conform these statements to actual results. Investors should refer to the risks disclosed in the Company's reports filed from time to time with the Securities and Exchange Commission and available at www.sec.gov.